Acro Biomedical (ACBM) Gross Profit (2017 - 2022)

Acro Biomedical's Gross Profit history runs 6 years deep, the most recent figure standing at $64000.0 for Q4 2022.

• In Q4 2022, Gross Profit fell 57.33% year-over-year to $64000.0; the TTM figure through Sep 2023 stood at $64000.0 (down 71.74% YoY), while the FY2022 annual figure was $140500.0, down 45.86% from the prior year.
• Gross Profit was $64000.0 for Q4 2022 at Acro Biomedical, down from $76500.0 in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $252600.0 in Q3 2018 to a low of $12096.0 in Q4 2019.
• Historically, Gross Profit has averaged $126890.9 across 5 years, with a median of $135400.0 in 2018.
• The sharpest annual moves came in 2019 and 2022: Gross Profit plunged 91.07% in 2019, then jumped 159.32% in 2022.
• A 5-year view of Gross Profit shows it stood at $135400.0 in 2018, then slumped by 91.07% to $12096.0 in 2019, then jumped by 1217.82% to $159404.0 in 2020, then fell by 5.9% to $150000.0 in 2021, then sank by 57.33% to $64000.0 in 2022.
• The last three Gross Profit figures came in at $64000.0 (Q4 2022), $76500.0 (Q1 2022), and $150000.0 (Q4 2021), per Business Quant data.